Alzheimer's amyloid fibrils: Structure and assembly

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1502, Issue 1, 2000, Pages 16-30

  Serpell, Louise C ^a  

^a MRC LABORATORY OF MOLECULAR BIOLOGY   (United Kingdom)

Author keywords

Alzheimer's disease; Amyloid; Beta sheet; Fibril; Structure

Indexed keywords

AMYLOID;

ALZHEIMER DISEASE; ELECTRICITY; FIBER; FIBRIN POLYMERIZATION; HUMAN; HUMAN TISSUE; HYDROGEN BOND; MICROSCOPY; PRIORITY JOURNAL; REVIEW; SENILE PLAQUE; STRUCTURE ANALYSIS;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ANIMALS; CONGO RED; HUMANS; MICROSCOPY, ATOMIC FORCE; MOLECULAR STRUCTURE; NEURONS; PEPTIDE FRAGMENTS; PROTEIN CONFORMATION; PROTEIN STRUCTURE, SECONDARY; SENILE PLAQUES; SOLUBILITY; X-RAY DIFFRACTION;

EID: 0034718157     PISSN: 09254439     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0925-4439(00)00029-6     Document Type: Review

References (91)

1. Selkoe D.J. The molecular pathology of Alzheimer's disease. Neuron. 6:1991;487-498.
2. Sunde M., Blake C. From the globular to the fibrous state: protein structure and structural conversion in amyloid formation. Q. Rev. Biophys. 31:1998;1-39.
3. Sunde M., Serpell L., Bartlam M., Fraser P., Pepys M., Blake C. Common core structure of amyloid fibrils by synchrotron X-ray diffraction. J. Mol. Biol. 273:1997;729-739.
4. Shirahama T., Cohen A.S. High resolution electron microscopic analysis of the amyloid fibril. J. Cell Biol. 33:1967;679-706.
5. A.S. Cohen, T. Shirahama, M. Skinner, Electron microscopy of amyloid, in: I.R. Harris (Ed.), Electron Microscopy of Protein, 1982, Academic Press, London, pp. 165-205.
6. Eanes E.D., Glenner G.G. X-ray diffraction studies on amyloid filaments. J. Histochem. Cytochem. 16:1968;673-677.
7. Fraser P., Duffy L., O'Malley M., Nguyen J., Inouye H., Kirschner D. Morphology and antibody recognition of synthetic β-amyloid peptides. J. Neurosci. Res. 28:1991;474-485.
8. Fraser P.E., Nguyen J.T., Surewicz W.K., Kirschner D.A. pH dependent structural transitions of Alzheimers amyloid peptides. Biophys. J. 60:1991;1190-1201.
9. Fraser P.E., Nguyen J.T., Inouye H., Surewicz W.K., Selkoe D.J., Podlisny M.B., Kirschner D.A. Fibril formation by primate, rodent and Dutch-hemorrhagic analogues of Alzheimer amyloid β-protein. Biochemistry. 31:1992;10716-10723.
10. Halverson K., Fraser P., Kirschner D., Lansbury P. Molecular determinants of amyloid deposition in Alzheimers disease: Conformational studies of synthetic β-protein fragments. Biochemistry. 29:1990;2639-2644.
11. Hilbich C., Kisters-Woike B., Reed J., Masters C., Beyreuther K. Aggregation and secondary structure of synthetic amyloid βA4 peptides of Alzheimer's disease. J. Mol. Biol. 218:1991;149-163.
12. Serpell L., Sunde M., Blake C. The molecular basis of amyloidosis. Cell. Mol. Life Sci. 53:1997;871-887.
13. Soto C., Branes M., Alvarez J., Inestrosa N. Structural determinants of the Alzheimer's amyloid beta-peptide. J. Neurol. Chem. 63:1994;1191-1198.
14. Kirschner D., Inouye H., Duffy L., Sinclair A., Lind M., Selkoe D. Synthetic peptide homologous to β-protein from Alzheimer's disease forms amyloid-like fibrils in vitro. Proc. Natl. Acad. Sci. USA. 84:1987;6953-6957.
15. Barrow C.J., Zagorski M.G. Solution structures of β-peptide and its constituent fragments relation to amyloid deposition. Science. 253:1991;179-182.
16. Zagorski M., Barrow C. NMR studies of amyloid β-peptide: Proton assignments, secondary structure and mechanism of an α-helix-β-sheet conversion for a homologous, 28 residue, N-terminal fragment. Biochemistry. 31:1992;5621-5631.
17. 1H NMR of Aβ amyloid peptide congeners in water solution. Conformation changes with plaque competence. Biochemistry. 34:1995;5191-5200.
18. Talafous J., Marcinowski K., Klopman G., Zagorski M. Solution structure of residues 1-28 of the amyloid β-peptide. Biochemistry. 33:1994;7788-7796.
19. Sorimachi K., Craik D. Structure determination of extracellular fragments of amyloid proteins involved in Alzheimer's disease and Dutch-type hereditary cerebral haemorrhage with amyloidosis. Eur. J. Biochem. 219:1994;237-251.
20. Fletcher F., Keire D. The interaction of β-amyloid protein fragment (12-28) with lipid environments. Protein Sci. 6:1997;666-675.
21. Benzinger T., Gregory D., Burkoth T., Miller-Auer H., Lynn D., Botto R., Meredith S. Propagating structure of Alzheimer's β-amyloid (10-35) is parallel β-sheet with residues in exact register. Proc. Natl. Acad. Sci. USA. 95:1998;13407-13412.
22. ElAgnaf O., Guthrie D., Walsh D., Irvine G. The influence of the central region containing residues 19-25 on the aggregation properties and secondary structure of Alzheimer's β-amyloid peptide. Eur. J. Biochem. 256:1998;560-569.
23. Kohno T., Kobayashi K., Maeda T., Sato K., Takashima A. Three-dimensional structures of the amyloid β peptide (25-35) in membrane-mimicking environment. Biochemistry. 35:1996;16094-16104.
24. Terzi E., Holzemann G., Seelig J. Alzheimer β-amyloid peptide 25-35: Electrostatic interactions with phospholipid membranes. Biochemistry. 33:1994;7434-7441.
25. Laczko I., Holly S., Konya Z., Soos K., Varga J., Hollosi M., Penke B. Conformational mapping of amyloid peptides from the putative neurotoxic 25-35 region. Biochem. Biophys. Res. Commun. 205:1994;120-126.
26. Lansbury P., Costa P., Griffiths J., Simon E., Auger M., Halverson K., Kocisko D., Hendsch Z., Ashburn T., Spencer R., Tidor B., Griffin R. Structural model for the β-amyloid fibril based on interstrand alignment of an antiparallel-sheet comprising a C-terminal peptide. Nature Struct. Biol. 2:1995;990-998.
27. Shen C.-L., Murphy R.M. Solvent effects on self assemply of β-amyloid peptide. Biophys. J. 69:1995;640-651.
28. Shen C.-L., Fitzgerald M., Murphy R. Effect of acid predissolution on fibril size and fibril flexibility of synthetic β-amyloid peptide. Biophys. J. 67:1994;1238-1245.
29. Soto C., Castano E., Frangione B., Inestrosa N. The α-helical to β-sheet transition in the amino-terminal fragment of the amyloid β-peptide modulates amyloid formation. J. Biol. Chem. 270:1995;3063-3067.
30. Tomski S., Murphy R. Kinetics of aggregation of synthetic β-amyloid peptide. Arch. Biochem. Biophys. 294:1992;630-638.
31. Coles M., Bicknell W., Watson A., Fairlie D., Craik D. Solution structure amyloid β-peptide (1-40) in a water-micelle environment. Is the membrane-spanning domain where we think it is? Biochemistry. 37:1998;11064-11077.
32. Watson A., Fairlie D., Craik D. Solution structure of methionine-oxidized amyloid β-peptide (1-40). Does oxidaton affect conformational switching? Biochemistry. 37:1998;12700-12706.
33. Sticht H., Bayer P., Willbold D., Dames S., Hilbich C., Beyreuther K., Frank R., Rosch P. Structure of amyloid A4(1-40)-peptide of Alzheimer's disease. Eur. J. Biochem. 233:1995;293-298.
34. Malinchik S.B., Inouye H., Szumowski K., Kirschner D. Structural analysis of Alzheimer's β(1-40) amyloid: protofilament assembly of tubular fibrils. Biophys. J. 74:1998;537-545.
35. Shao H., Jao S., Ma J., Zagorski M. Solution structures of micelle-bound amyloid β-(1-40) and β-(1-42) peptides of Alzheimer's disease. J. Mol. Biol. 285:1999;755-773.
36. Wood S., Maleeff B., Hart T., Wetzel R. Physical, morphological and functional differences between pH 5.8 and 7.4 aggregates of the Alzheimer's amyloid peptide Aβ J. Mol. Biol. 256:1996;870-877.
37. Kirschner D., Abraham C., Selkoe D. X-ray diffraction from intraneuronal paired helical filaments and extra-neuronal amyloid fibres in Alzheimers disease indicates cross β conformation. Proc. Natl. Acad. Sci. USA. 83:1986;503-507.
38. Norstedt C., Naslund J., Tjernberg L., Karlstrom A., Thyberg J., Terenius L. The Alzheimer Aβ peptide develops protease resistance in associaction with its polymerization into fibrils. J. Biol. Chem. 269:1994;30773-30776.
39. Zhang S., Casey N., Lee J. Residual structure in the Alzheimer's disease peptide: probing the origin of a central hydrophobic cluster. Folding Design. 3:1998;413-422.
40. Levy E., Carman M., Fernadez-Madrid I., Lieberburg I., Poser M., Van Duinen S., Bots G., Luyendijk W., Frangione B. Mutation of the Alzheimers disease gene in hereditary cerebral haemorrhage, Dutch type. Science. 248:1990;1124-1126.
41. Wisniewski T., Ghiso J., Frangione B. Peptides homologous to the amyloid protein of Alzheimers disease containing glutamine for a glutamic acid substitution have accelerated amyloid fibril formation. Biochem. Biophys. Res. Coomun. 179:1991;1247-1254.
42. Tjernberg L., Callaway D., Tjernberg A., Hahne S., Lilliehook C., Terenius L., Thyberg J., Norstedt C. A molecular model of Alzheimer's amyloid-β peptide fibril formation. J. Biol. Chem. 274:1999;12619-12625.
43. Lansbury P. Evolution of amyloid: what normal protein folding may tell us about fibrillogenesis and disease. Proc. Natl. Acad. Sci. USA. 96:1999;3342-3344.
44. Roher A.E., O'Chaney M., Kuo Y., Webster S.D., Stine W.B., Haverkams L.J., Woods A.S., Cotter R.J., Tuohy J.M., Krafft G.A., Bonnell B.S., Emmerling M.R. Morphology and toxicity of Aβ-(1-42) dimer derived from neuritic and vascular amyloid deposits of Alzheimer's disease. J. Biol. Chem. 271:1996;20631-20635.
45. Garzon-Rodriguez W., Sepulveda-Becerra M., Milton S., Glabe C. Soluble amyloid Aβ-(1-40) exists as a stable dimer at low concentrations. J. Biol. Chem. 272:1997;21037-21044.
46. Seilheimer B., Bohrmann B., Bondolfi L., Muller F., Stuber D., Dobeli H. The toxicity of the Alzheimer's β-amyoid peptide correlates with a distinct fiber morphology. J. Struct. Biol. 119:1997;59-71.
47. Kowalewski T., Holtzman D. In situ atomic force microscopy study of Alzheimer's β-amyloid peptide on different substrates: New insights into mechanism of β-sheet formation. Proc. Natl. Acad. Sci. USA. 96:1999;3688-3693.
48. Snyder S., Ladror U., Wade W., Wang G., Barrett L., Matayoshi E., Huffaker H., Kafft G., Holzman T. Amyloid-β aggregation: selective inhibition of aggregation in mixtures of amyloid with different chain lengths. Biophys. J. 67:1994;1216-1228.
49. Lomakin A., Chung D., Benedek G., Kirschner D., Teplow D. On the nucleation and growth of amyloid β-protein fibrils: detection of nuclei and quantification of rate constants. Proc. Natl. Acad. Sci. USA. 93:1996;1125-1129.
50. Harper J., Wong S., Lieber C., Lansbury P. Observation of metastable Aβ amyloid protofibrils by atomic force microscopy. Chem. Biol. 6:1997;119-125.
51. Walsh D., Lomakin A., Benedek G., Condron M., Teplow D. Amyloid β-protein fibrillogenesis. J. Biol. Chem. 272:1997;22364-22372.
52. Chaney M.O., Webster S., Kuo Y., Roher A. Molecular modelling of the Aβ1-42 peptide from Alzheimer's disease. Protein Eng. 11:1998;761-767.
53. Stine W., Snyder S., Ladror U., Wade W., Miller M., Perun T., Holzman T., Krafft G. The nanometer-scale structure of amyloid-β visualized by atomic force microscopy. J. Protein Chem. 15:1996;193-203.
54. Inouye H., Fraser P., Kirschner D. Structure of β-crystallite assemblies by Alzheimer β amyloid protein analogues: Analysis by X-ray diffraction. Biophys. J. 64:1993;502-519.
55. Serpell L., Sunde M., Fraser P., Luther P.K., Morris E., Sandgren O., Lundgren E., Blake C. The examination of the structure of the transthyretin amyloid fibril by image reconstruction from electron micrographs. J. Mol. Biol. 254:1995;113-118.
56. Blake C., Serpell L. Synchrotron X-ray studies suggest that the core of the transthyretin amyloid fibril is a continuous β-helix. Structure. 4:1996;989-998.
57. Geddes A.J., Parker K.D., Atkins E.D.T., Beighton E. 'Cross β' conformation in protein. J. Mol. Biol. 32:1968;343-358.
58. Pauling L., Corey R. Two β-pleated sheet configurations of polypeptide chains involving both cis- and trans- amide groups. Proc. Natl. Acad. Sci. USA. 39:1953;247-252.
59. Inouye H. X-ray-scattering from a discrete helix with cumulative angular and translational disorders. Acta Crystallogr. A. 50:1994;644-646.
60. Fraser R., MacRae T. An investigation of the structure of β-keratin. J. Mol. Biol. 5:1962;457-466.
61. Selkoe D.J., Abraham C., Ihara Y. Brain transglutaminase - in vitro crosslinking of human neurofilament proteins into insoluble polymers. Proc. Natl. Acad. Sci. USA. 79:1982;6070-6074.
62. Rasmussen L., Sorensen E., Petersen T., Gliemann J., Jensen P. Identification of glutamine and lysine residues in Alzheimer amyloid β-A4 peptide responsible for transglutaminase-catalyzed homopolymerization and cross-linking to alpha(2)M receptor. FEBS Lett. 338:1994;161-166.
63. Ho G., Gregory E., Smirmova I., Zoubine M., Festoff B. Cross-linking of β-amyloid protein precursor catalyzed by tissue transglutaminase. FEBS Lett. 349:1994;151-154.
64. Dudek S., Johnson G. Transglutaminase facilitates the formation of polymers of the β-amyloid peptide. Brain Res. 651:1994;129-133.
65. Ikura K., Takahata K., Sasaki R. Cross-linking of a synthetic partial-length (1-28) peptide of the Alzheimer β/A4 amyloid protein by transglutaminase. FEBS Lett. 349:1993;109-111.
66. Marsh R.E., Corey R.B., Pauling L. Biochim. Biophys. Acta. 16:1955;1-34.
67. Yoder M., Lietzke S., Jurnak F. Unusual structural features in the parallel β-helix in pectate lyases. Structure. 1:1993;241-251.
68. Yoder M., Keen N., Jurnak F. New domain motif - the structure of pectate lyase-C, a secreted plant virulence factor. Science. 260:1993;1503-1506.
69. Yoder M., Jurnak F. Protein motifs. 3. The parallel β-helix and other coiled folds. FASEB J. 9:1995;335-342.
70. Sieber V., Jurnak F., Moe G. Circular dichroism of the parallel β-helical proteins pectate lyase-C and lyase-E. Proteins Struct. Funct. Genet. 23:1995;32-37.
71. Steinbacher S., Seckley R., Miller D., Steipe B., Huber R., Reinemer P. Crystal-structure of P22 tailspike protein - interdigitated subunits in a thermostable trimer. Science. 265:1994;383-386.
72. Raetz C., Roderick S. A left-handed parallel β-helix in the structure of UDP-N-acetylglucosamine acyltransferase. Science. 270:1995;997-1000.
73. Lazo N., Downing D. Amyloid fibrils may be assembled from β-helical protofibrils. Biochemistry. 37:1998;1731-1735.
74. Cruz L., Urbanc B., Buldyrev S., Christie R., Gomez-Isla T., Havlin S., McNamara M., Stanleu H., Hyman B. Aggregation and disaggregation of senile plaques in Alzheimer's disease. Proc. Natl. Acad. Sci. USA. 94:1997;7612-7616.
75. Choo L., Wetzel D., Halliday W., Jackson M., LeVine S., Mantsch H. In situ characterization of β-amyloid in Alzheimer's disease tissue by synchrotron Fourier transform infrared microspectroscopy. Biophys. J. 71:1996;1672-1679.
76. Snow A., Wight T. Proteoglycans in the pathogenesis of Alzheimer's disease and other amyloidoses. Neurobiol. Aging. 10:1989;481-497.
77. Pepys M.B., Rademacher T.W., Supavadee A.-C., Williams P., Noble G.E., Hutchinson W.L., Hawkins P.N., Nelson S.R., Gallimore J.R., Herbert J., Hutton T., Dwek R.A. Human serum amyloid P component is an invariant constituent of amyloid deposits and has a uniquely homogeneous glycostructure. Proc. Natl. Acad. Sci. USA. 91:1994;5602-5606.
78. Strittmatter W.K., Huang W.J., Dong L., Salvesen G.S., Pericak-Vance M., Schmechel D., Saunders A.M., Goldgaber D., Roses A. Binding of human apolipoprotein E to synthetic amyloid β-peptide: Isoform-specific effects for late-onset Alzheimers disease. Proc. Natl. Acad. Sci. USA. 90:1993;8098-8102.
79. Utermann G. The apolipoprotein E connection. Curr. Biol. 4:1994;362-365.
80. Abraham C., Selkoe D., Potter H. Immunochemical identification of the serine protease inhibitor α-1 antichymotrypsin in the brain amyloid deposits of Alzheimer's disease. Cell. 52:1988;487-501.
81. McGeer P.L., McGeer E.G. The inflammatory response system of brain: Implications for therapy of Alzheimer and other neurodegenerative diseases. Brain Res. Rev. 21:1995;195-218.
82. Fraser P., Nguyen J., Chin D., Kirschner D. Effects of sulphate ions on Alzheimer β/A4 peptide assemblies for amyloid fibril-proteoglycan interactions. J. Neurochem. 59:1992;1531-1540.
83. Brunden K.R., Richter-Cook N.J., Chaturvedi N., Frederickson R.C.A. pH dependent binding of synthetic β-amyloid peptides to glycosaminoglycans. J. Neurochem. 61:1993;2147-2154.
84. 2+-dependent binding of human serum amyloid P component to Alzheimer's β-amyloid peptide. J. Biol. Chem. 270:1995;10392-10394.
85. Emsley J., White J., O'Hara B., Oliva G., Srinivasan N., Tickle I., Blundell T., Pepys M., Wood S. Structure of pentarmeric human serum amyloid P component. Nature. 367:1994;338-345.
86. 2+ region of human SAP component and other pentraxins. Protein Sci. 1:1992;700-709.
87. Tennent G., Lovat L., Pepys M. Serum amyloid P component prevents proteolysis of the amyloid fibrils of Alzheimer's disease and systemic amyloidosis. Proc. Natl. Acad. Sci. USA. 92:1995;4299-4303.
88. LaDu M., Falduto M., Manelli A., Reardon C., Getz G., Frail D. Isoform-specific binding of apolipoprotein E to β-amyloid. J. Med. Biol. 269:1994;23403-23406.
89. Abraham C., Shirahama T., Potter H. α-1 Antichymotypsin is associated solely with amyloid deposition containing the β-protein. Amyloid and cell localization of α-1 antichymotrypsin. Neurobiol. Aging. 11:1990;123-129.
90. 1-Antichymotrypsin binding to Alzheimer Aβ peptides is sequence specific and induces fibril dissaggregation in vitro. J. Neurochem. 61:1993;298-305.
91. Ma J., Yee A., Brewer B., Das S., Potter H. Amyloid-associated proteins α1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer β-protein into filaments. Nature. 372:1994;92-94.